Bone News and Research

RSS

Circadian clock genes are involved in healing from surgery, study shows

If you have just had knee, shoulder or hip surgery, you may want to take anti-inflammatories in the morning or at noon, but not at night.

21 Jan 2020

Surgical complications are much more likely in smokers

A new study shows that smoking tobacco puts you at a greatly increased risk for complications after surgery. This includes heart and lung damage, poor wound healing and a higher chance of complications. However, quitting smoking, even as late as 4 weeks before the surgery, improves the chances of having a good post-operative result and fewer complications.

21 Jan 2020

Powerful combination of experimental drugs reverses osteoarthritis in rats

People with osteoarthritis, or "wear and tear" arthritis, have limited treatment options: pain relievers or joint replacement surgery.

21 Jan 2020

Discovery of potent immune cell that can destroy multiple types of cancer

The immune system is the body’s defense against harmful pathogens that may enter the body. Immune cells, such as white blood cells and macrophages work hand in hand to fight off disease-causing microorganisms, including cancer.

21 Jan 2020

Taking high dose of vitamin D linked lower blood pressure in overweight children

Overweight and obese vitamin D-deficient children who took a relatively high dose of vitamin D every day for six months had lower blood pressure and improved insulin sensitivity than their peers who took a lower dose, according to the results of a UPMC Children's Hospital of Pittsburgh clinical trial reported in The American Journal of Clinical Nutrition.

21 Jan 2020

Raman spectroscopy can be used to diagnose the state of thrombocytes in cardiovascular patients

A team of scientists from Immanuel Kant Baltic Federal University used Raman spectroscopy to study the thrombocytes of patients with cardiovascular diseases and compared their spectra with those of healthy people.

21 Jan 2020

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.

21 Jan 2020

Lab tests reveal that newly discovered T-cell can kill various types of cancer

Scientists have discovered a T-cell receptor that has proven effective in targeting a variety of cancers in mice and in human cells within the lab.

21 Jan 2020

Study demonstrates striking improvements in bone marrow transplants since mid-2000s

A bone marrow transplant can be a lifesaving treatment, but it can come with life-threatening risks.

20 Jan 2020

Liver mesenchymal stromal cells could be a better option for many therapeutic applications

Mesenchymal stromal cells from fat tissue and bone marrow are widely used in therapeutic trials for their anti-inflammatory qualities, but new Mayo Clinic research finds that liver cells may be of greater value.

20 Jan 2020

Certain enzymes implicated in diseases like cancer also destroy each other

Like motley bandits, certain enzymes implicated in cancer and other diseases also annihilate each other. A new study reveals details of their mutual foils in the hopes that these behaviors can be leveraged to fight the enzymes' disease potential.

20 Jan 2020

Enzymes that cannibalize each other and promote cancer

A new study to be published this week in the journal The Proceedings of the National Academy of Sciences in the week of January 20, 2020. shows that certain human enzymes play dual roles in health and disease. Not only do they promote the occurrence of cancer and some other illnesses, they also eliminate one another rather like cannibals. The researchers hope this behaviour can be exploited to prevent these enzymes from causing human disease.

20 Jan 2020

Powered medical devices offer benefits to surgeons

Many people still have a classical view of surgery —skilled surgeons in scrubs manually cutting, inspecting and sewing patients back up again. However, surgery equipment has come a long way.

20 Jan 2020

Surgeons restore full ambulatory ability in double-amputee teenager with flesh-eating disease

In a medical first in Quebec, Dr. Panagiotis (Peter) Glavas and his team at CHU Sainte-Justine and Universite de Montreal have managed to restore full ambulatory ability in a severely handicapped teenager who was left a double-amputee after getting flesh-eating disease in infancy.

17 Jan 2020

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

It is known that the tumor microenvironment plays an important role in the progression of cancer. But could estrogen present in this microenvironment facilitate the growth of liver metastases in women affected by colon, pancreatic and lung cancers?

17 Jan 2020

Virtual PT after knee replacement provides good outcomes with lower costs

A virtual system for in-home physical therapy (PT) provides good outcomes for patients undergoing rehabilitation following total knee arthroplasty (TKA) - with lower costs than traditional in-person PT, reports a study in the January 15, 2020 issue of The Journal of Bone & Joint Surgery.

16 Jan 2020

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

A stem cell transplant - also called a bone marrow transplant - is a common treatment for blood cancers, such as acute myeloid leukemia.

16 Jan 2020

Women who have more sex less likely to have early menopause

Women who have sex more are at a reduced risk of experiencing early menopause, a new study found. The new finding raises the possibility of lifestyle practices as a predictor of when menopause will occur.

15 Jan 2020

Study explains “Swiss-cheese” bones suspected to cause lower back pain

Researchers at the John Hopkins University School of Medicine say they have added to the evidence that age-related changes to spinal cartilage tissue could invite painful nerve overgrowth that causes lower back pain.

15 Jan 2020

Biomaterial-based vaccine has potential to completely eliminate AML cells

Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then lead to disease recurrence in nearly half of treated patients.

14 Jan 2020

Bone News and Research

Circadian clock genes are involved in healing from surgery, study shows

Surgical complications are much more likely in smokers

Powerful combination of experimental drugs reverses osteoarthritis in rats

Discovery of potent immune cell that can destroy multiple types of cancer

Taking high dose of vitamin D linked lower blood pressure in overweight children

Raman spectroscopy can be used to diagnose the state of thrombocytes in cardiovascular patients

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Lab tests reveal that newly discovered T-cell can kill various types of cancer

Study demonstrates striking improvements in bone marrow transplants since mid-2000s

Liver mesenchymal stromal cells could be a better option for many therapeutic applications

Certain enzymes implicated in diseases like cancer also destroy each other

Enzymes that cannibalize each other and promote cancer

Powered medical devices offer benefits to surgeons

Surgeons restore full ambulatory ability in double-amputee teenager with flesh-eating disease

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

Virtual PT after knee replacement provides good outcomes with lower costs

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Women who have more sex less likely to have early menopause

Study explains “Swiss-cheese” bones suspected to cause lower back pain

Biomaterial-based vaccine has potential to completely eliminate AML cells

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News